Skip to content
OpenCapital
Get started

Procter & Gamble PG Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

Colgate-Palmolive logo
Colgate-PalmoliveCL
$341M-7.8%
3M logo
3MMMM
$48M-18.6%
CVS Health logo
CVS HealthCVS
$181M0.0%
Kimberly-Clark logo
Kimberly-ClarkKMB
——

Other financials

Income statement

See full
Revenue$21.2B+7.4%
Gross profit$10.5B+4.3%
Operating income$4.6B+0.4%
Net income$3.9B+4.3%
EPS (diluted)$1.63+5.8%

Balance sheet

See full
Cash & equivalents$12.3B+35.0%
Total debt$23.9B-30.1%
Total assets$128.38B+4.4%

Cash flow

See full
Operating cash flow$4.0B+9.2%
CapEx$1.0B+18.6%
Free cash flow$3.0B+6.3%

Valuation

See full
Market cap$350.17B-16.0%
Enterprise value$361.72B-18.2%
P/E21.1×-5.8×
P/S4×-0.9×

Profitability

See full
Gross margin50.3%-1.0pp
Operating margin23.2%-0.6pp
Net margin19.2%+0.7pp

Returns & leverage

See full
Current ratio0.7×0.0×

Where this comes from

Reported directly by Procter & Gamble in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: Procter & Gamble’s 10-Q, filed April 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Procter & Gamble's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Procter & Gamble's noncontrolling interests in subsidiaries?
Procter & Gamble (PG) reported noncontrolling interests in subsidiaries of $226M in Q1 2026.
How has Procter & Gamble's noncontrolling interests in subsidiaries changed year-over-year?
Procter & Gamble's noncontrolling interests in subsidiaries decreased by 17.2% year-over-year, from $273M to $226M.
What is the long-term trend for Procter & Gamble's noncontrolling interests in subsidiaries?
Over 4 years (2021 to 2025), Procter & Gamble's noncontrolling interests in subsidiaries has grown at a -0.4% compound annual growth rate (CAGR), from $276M to $272M.